Cencora
Open
$280.66
Prev. Close
$280.66
High
$281.71
Low
$280.56
Market Snapshot
$54.79B
21.5
7.11
$303.19B
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. The company is headquartered in Conshohocken, Pennsylvania and currently employs 51,000 full-time employees. The firm helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. The company is headquartered in Conshohocken, Pennsylvania and currently employs 51,000 full-time employees. The firm helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Recently from Cashu
Cencora Partners with Kite to Enhance CAR T-Cell Therapy Distribution in Oncology
Cencora's new partnership in the CAR T-cell therapy space marks a significant move in enhancing access to innovative cancer treatments. The company, known for its focus on specialized healthcare distr…
Vanguard Capital Management Acquires 7.3% Stake in Cencora, Boosting Pharmaceutical Distribution Position
Cencora, a key player in the pharmaceutical distribution industry, attracts attention as Vanguard Capital Management announces a substantial investment in the company. With a disclosed 7.3% stake repo…
Cencora Expands Specialty Retina Care With EyeSouth Acquisition, Enhancing Market Presence and Earnings.
Cencora, a leading company in health and specialty services, is poised for significant growth following its recent acquisition of EyeSouth’s retina business. This strategic move amplifies Cencora's pr…
Cencora Announces CFO Retirement, Prepares for Leadership Transition and Future Growth Strategy.
Cencora Faces Leadership Transition with CFO Retirement Announcement Cencora announces the impending retirement of Chief Financial Officer James Cleary, effective June 30, 2026. Cleary has steered the…